CCM vs RDNT vs USPH vs AMSF vs ARAY

For growth investors, U.

S. Physical Therapy, Inc. (USPH) is the stronger pick with 16. 3% revenue growth year-over-year, versus -28. 6% for Concord Medical Services Holdings Limited (CCM). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 3x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Concord Medical Services Holdings Limited (CCM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, AMERISAFE, Inc.

(AMSF) is the cheapest at 12. 3x versus U. S. Physical Therapy, Inc. at 41. 5x. On forward P/E, Concord Medical Services Holdings Limited is actually cheaper at 1. 2x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, RadNet, Inc.

(RDNT) delivered a total return of +147. 1%, compared to -93. 9% for Accuray Incorporated (ARAY). Over 10 years, the gap is even starker: RDNT returned +947. 4% versus ARAY's -94. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), AMERISAFE, Inc.

(AMSF) is the lower-risk stock at 0. 23β versus Accuray Incorporated's 2. 42β — meaning ARAY is approximately 948% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 2% for Concord Medical Services Holdings Limited — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), U.

S. Physical Therapy, Inc. (USPH) is pulling ahead at 16. 3% versus -28. 6% for Concord Medical Services Holdings Limited (CCM). On earnings-per-share growth, the picture is similar: Accuray Incorporated grew EPS 90. 3% year-over-year, compared to -768. 4% for RadNet, Inc.. Over a 3-year CAGR, RDNT leads at 12. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

AMERISAFE, Inc.

(AMSF) is the more profitable company, earning 14. 9% net margin versus -80. 3% for Concord Medical Services Holdings Limited — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus -138. 6% for CCM. At the gross margin level — before operating expenses — AMSF leads at 46. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Concord Medical Services Holdings Limited (CCM) trades at 1.

2x forward P/E versus 91. 8x for RadNet, Inc. — 90. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USPH: 72. 9% to $102. 00.

In this comparison, AMSF (8.

4% yield), USPH (3. 1% yield) pay a dividend. CCM, RDNT, ARAY do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, AMERISAFE, Inc.

(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 8. 4% yield). Accuray Incorporated (ARAY) carries a higher beta of 2. 42 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AMSF: +31. 8%, ARAY: -94. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CCM (Healthcare) and RDNT (Healthcare) and USPH (Healthcare) and AMSF (Financial Services) and ARAY (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CCM is a small-cap quality compounder stock; RDNT is a small-cap quality compounder stock; USPH is a small-cap high-growth stock; AMSF is a small-cap deep-value stock; ARAY is a small-cap quality compounder stock. USPH, AMSF pay a dividend while CCM, RDNT, ARAY do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.